LiveWorld (OTCMKTS:LVWD) & Genius Sports (NYSE:GENI) Head to Head Survey

The piece compares LiveWorld and Genius Sports across profitability, valuation, volatility and ownership metrics, finding Genius Sports the stronger pick on most measures despite operating losses. LiveWorld reported $11.35M revenue, roughly $60k net income (2.17% net margin), ROE 4.71% and low beta (0.17); Genius Sports reported $510.89M revenue, a $63.04M net loss (‑19.71% margin), ROE ‑14.39%, higher beta (1.94), 81.9% institutional ownership, a 4.56 price/sales and negative EPS (‑$0.47). MarketBeat consensus ratings favor Genius (rating score 2.90) with a $14.90 target implying ~37.6% upside, which underpins the article’s conclusion that analysts prefer Genius over LiveWorld.

Analysis

Market structure: Genius Sports (GENI) is positioned to benefit from rising demand for live sports data, streaming and integrity solutions — institutional ownership (81.9%) and a $14.90 consensus PT imply ~38% upside vs peers. Winners include sportsbooks, leagues and media buyers who pay for exclusive data/streaming; losers are small social agencies and commoditized data resellers with no exclusive rights. Constrained supply of verified live-data (rights/licensing) supports pricing power if GENI secures renewals; LiveWorld (LVWD) is unlikely to compete at scale given $11m revenue vs GENI’s $511m.

Risk assessment: Near-term (days–weeks) execution risk centers on upcoming quarterly results and any missed league deals; medium-term (3–12 months) tail risks include regulatory action on sports-betting integrity or loss of exclusive rights, and FX/headline liquidity pressure for a London-listed operator. Hidden dependencies: large-client concentration, sports calendar seasonality (major events can swing revenue 10–30% q/q), and technology uptime — an outage could trigger contractual penalties. Key catalysts: contract announcements, Qs, and regulatory guidance in the next 60–180 days.

Trade implications: Direct trade — establish a 2–4% long position in GENI with conviction ahead of expected rights/cycle catalysts and add on pullbacks to $9–10; consider a 1% tactical short in LVWD (OTC: LVWD) due to illiquidity and weak scale. Options — buy 6–9 month GENI calls (near $12 strike) or sell 3-month cash-secured puts at ~$10 to collect premium; size options to <=2% notional. Exit rules: take profits at +40–60% or at PT $14.90, stop-loss at -25%.

Contrarian angle: Consensus emphasizes top-line growth but underweights path-to-profit; GENI’s current -19.7% net margin masks operating leverage — a 10–15% incremental gross margin expansion could swing EPS materially in 12–24 months. Conversely, market underprices execution risk: a single lost rights deal could wipe >15–25% of forward revenue. Historical parallels: rights-driven re-ratings (e.g., data/rights vendors) support a momentum re-rate if GENI prints two consecutive beats, but regulatory scrutiny could produce asymmetric downside.

Key Decisions for Investors

• Initiate a 2–4% long position in Genius Sports (GENI) within 2–6 weeks, target exit at the $14.90 consensus price target (~+38%); add on pullbacks to $9–10, set a tactical stop-loss at -25% from entry.
• Establish a 1% short or selective put-position against LiveWorld (OTC: LVWD) as a liquidity/scale short; close or reduce if bid/ask spreads tighten <10% or if insider holdings increase >5% within 60 days.
• Use options to express bullish view on GENI: buy 6–9 month calls (approximately $12 strike) sized to 1–2% portfolio risk, or sell 3-month cash-secured puts at ~$10 to collect premium; avoid net leverage >2% notional.
• Monitor three specific catalysts over the next 30–180 days (new league/data contracts, next two quarterly reports, and any UK/US regulatory guidance on sports-betting integrity); add to GENI on two positive catalysts or reduce exposure by 50% on any one of: missed guide, loss of a top-3 client, or adverse regulatory action.